Le Lézard
Classified in: Health
Subject: FEA

Sectra's VNA and universal viewer for all enterprise imaging selected by UC Health in the US


LINKÖPING, Sweden and SHELTON, Conn., April 13, 2021 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has contracted with the University of California Health (UC Health) to provide the Sectra VNA, universal viewer, and worklist manager to its academic medical centers. UC San Diego Health is the first of the UC Health campuses to order and deploy the Sectra Enterprise Imaging solution of which Sectra will be the cross-departmental workflow engine and long-term archive for all imaging. Additionally, all breast radiologists, surgeons, pathologists, and orthopedists will utilize Sectra for viewing, diagnostics, surgical planning, and collaboration.

UC San Diego Health is one of six academic medical centers that comprise UC Health. They maintain a regional strategy with three hospitals as well as primary and urgent care clinics located throughout the San Diego region. UC Health provides care for 1.8 million patients each year.

"Sectra installed its Breast Imaging solution at UC San Diego Health several years ago and our organizations have developed a strong, trusted relationship. This new contract extends Sectra's solution, enterprise-wide, to support other clinical imaging areas and serve as the backbone for image management and archive across the Health System. We will interface with multiple third parties to deliver a seamless, highly integrated solution," says Anthony Grise, Vice President of Sales at Sectra, Inc. 

The contract, signed in March, provides enterprise imaging as a subscription service (Sectra One). This allows for an efficient means of scaling the system as volumes grow and easy expansion into other specialties and new functionality, as it becomes available.  

Sectra's enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra and why it's top-ranked in 'Best in KLAS' at medical.sectra.com.

About Sectra
Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit sectra.com.

CONTACT:

For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/sectra-s-vna-and-universal-viewer-for-all-enterprise-imaging-selected-by-uc-health-in-the-us,c3319109

The following files are available for download:

https://news.cision.com/sectra/i/sectra-medical-imaging,c2896303

Sectra medical imaging

 


These press releases may also interest you

at 23:19
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

at 22:00
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

at 20:05
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 19:30
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...



News published on and distributed by: